[go: up one dir, main page]

HK1070000A1 - Crystalline composition containing escitalopram - Google Patents

Crystalline composition containing escitalopram Download PDF

Info

Publication number
HK1070000A1
HK1070000A1 HK05102804A HK05102804A HK1070000A1 HK 1070000 A1 HK1070000 A1 HK 1070000A1 HK 05102804 A HK05102804 A HK 05102804A HK 05102804 A HK05102804 A HK 05102804A HK 1070000 A1 HK1070000 A1 HK 1070000A1
Authority
HK
Hong Kong
Prior art keywords
unit dosage
dosage form
solid unit
form according
temperature
Prior art date
Application number
HK05102804A
Other languages
English (en)
Chinese (zh)
Other versions
HK1070000B (en
Inventor
Troels Volsgaard Christensen
Ken Liljegren
Michiel Onne Elema
Lene Andresen
Shashank Mahashabde
Sebastian P. Assenza
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1070000(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HK1070000A1 publication Critical patent/HK1070000A1/xx
Publication of HK1070000B publication Critical patent/HK1070000B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
HK05102804.7A 2001-07-31 2002-07-25 Crystalline composition containing escitalopram HK1070000B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101164 2001-07-31
DKPA200101164 2001-07-31
PCT/DK2002/000513 WO2003011278A1 (en) 2001-07-31 2002-07-25 Crystalline composition containing escitalopram

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK06102593.1A Division HK1082407A (en) 2001-07-31 2005-04-04 Crystalline composition containing escitalopram

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK06102593.1A Addition HK1082407A (en) 2001-07-31 2005-04-04 Crystalline composition containing escitalopram

Publications (2)

Publication Number Publication Date
HK1070000A1 true HK1070000A1 (en) 2005-06-10
HK1070000B HK1070000B (en) 2007-11-30

Family

ID=

Also Published As

Publication number Publication date
CN1311819C (zh) 2007-04-25
US20080305164A1 (en) 2008-12-11
MA27349A1 (fr) 2005-06-01
NZ530157A (en) 2007-06-29
SI1414435T1 (en) 2005-06-30
EP1414435B1 (de) 2005-01-12
PL366995A1 (en) 2005-02-07
JP2010150283A (ja) 2010-07-08
JP5192568B2 (ja) 2013-05-08
RS8304A (en) 2006-12-15
US7420069B2 (en) 2008-09-02
CO5560540A2 (es) 2005-09-30
WO2003011278A1 (en) 2003-02-13
MEP2108A (xx) 2010-02-10
UA79930C2 (en) 2007-08-10
IL159326A0 (en) 2004-06-01
ATE286730T1 (de) 2005-01-15
JP5719811B2 (ja) 2015-05-20
JP2012211186A (ja) 2012-11-01
PE20030304A1 (es) 2003-03-27
IL159326A (en) 2010-05-31
PT1522539E (pt) 2007-03-30
DE60217932T2 (de) 2007-08-30
CA2451915A1 (en) 2003-02-13
BG108571A (en) 2005-02-28
CN1536997A (zh) 2004-10-13
HRP20080410A2 (en) 2008-10-31
MXPA04000849A (es) 2004-05-14
HRP20031073A2 (en) 2004-04-30
JP2011195591A (ja) 2011-10-06
EG24206A (en) 2008-10-21
DK1414435T3 (da) 2005-05-09
EP1522539B1 (de) 2007-01-24
EA200400243A1 (ru) 2004-06-24
ZA200309684B (en) 2004-12-22
AU2002355624B2 (en) 2006-02-02
EP1522539A1 (de) 2005-04-13
TNSN04021A1 (en) 2006-06-01
US6916941B2 (en) 2005-07-12
BR0206164A (pt) 2003-10-28
ES2233842T3 (es) 2005-06-16
CA2451915C (en) 2010-09-21
EA006213B1 (ru) 2005-10-27
TR200400189T2 (tr) 2004-12-21
DE60202615T2 (de) 2006-01-12
US20050147674A1 (en) 2005-07-07
DE60202615D1 (de) 2005-02-17
ES2280892T3 (es) 2007-09-16
NO328346B1 (no) 2010-02-01
DE60217932D1 (de) 2007-03-15
NO20040380L (no) 2004-01-28
AR034898A1 (es) 2004-03-24
JP2005525993A (ja) 2005-09-02
EP1414435A1 (de) 2004-05-06
MY126238A (en) 2006-09-29
HUP0401946A2 (hu) 2005-01-28
CY1106413T1 (el) 2011-10-12
JP4971477B2 (ja) 2012-07-11
DK1522539T3 (da) 2007-05-07
PT1414435E (pt) 2005-05-31
IS7077A (is) 2003-12-15
US20030212128A1 (en) 2003-11-13
CN1660074A (zh) 2005-08-31
ATE352546T1 (de) 2007-02-15
UY27404A1 (es) 2003-02-28
KR20040028947A (ko) 2004-04-03
HRPK20080410B3 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
JP5192568B2 (ja) エスシタロプラムを含む結晶性組成物
AU2002355624A1 (en) Crystalline composition containing escitalopram
AU2001100198B4 (en) Pharmaceutical composition containing citalopram
HK1070000B (en) Crystalline composition containing escitalopram
US20030109577A1 (en) Pharmaceutical composition containing citalopram
HK1082407A (en) Crystalline composition containing escitalopram
ZA200300561B (en) Pharmaceutical composition containing citalopram.
GB2376233A (en) Crystals of a pharmaceutically acceptable salt of citalopram wherein the median particle size of the crystals is at least 40 microns

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220724